Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VIVS
VIVS logo

VIVS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VIVS News

VivoSim Labs Expands NAMKind Services to Asia-Pacific Region

Jan 30 2026stocktwits

U.S. Stocks Decline in Morning Trading, Dow Jones Drops Over 100 Points

Jan 30 2026Benzinga

VivoSim Labs Expands NAMKind Services in Asia-Pacific

Jan 30 2026NASDAQ.COM

SanDisk Reports Strong Q2 Results, Shares Surge

Jan 30 2026Benzinga

VivoSim Labs Appoints Dr. Amar Sethi as Chief Scientific Officer to Drive 3D Toxicology Innovation

Jan 06 2026Globenewswire

Investors' Reactions to NIO's Surge in November Deliveries Across Its Diverse EV Lineup

Dec 13 2025Yahoo Finance

Alphabet Shares Rise Approximately 8%; Check Out 20 Stocks Making Moves in Premarket Trading

Oct 30 2025Benzinga

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

Aug 14 2025Newsfilter

VIVS Events

03/03 08:30
VivoSim Labs Appoints Dr. Arumugham Raghunathan as VP of Global Sales
VivoSim Labs announced the appointment of Dr. Arumugham Raghunathan, PhD as Vice President of Global Sales. Based in the Greater Boston area, Dr. Raghunathan will lead commercial expansion and secure strategic partnerships with biopharma innovators, established pharmaceutical companies, CROs/CDMOs, and research institutions. His focus will be on delivering VivoSim's liver and gastrointestinal toxicity solutions for earlier de-risking of drug candidates and clearer feasibility decisions throughout the development process. A seasoned executive, Dr. Raghunathan brings extensive experience building trusted, consultative relationships across drug discovery and advanced in vitro biology.
01/06 08:40
VivoSim Labs Appoints Amar Sethi as Chief Scientific Officer
VivoSim Labs announces it has appointed Amar Sethi, M.D., Ph.D. as its Chief Scientific Officer. At VivoSim, Dr. Sethi will lead scientific strategy across toxicology, translational models, bioanalytics, and next-generation new approach methodologies methodologies

VIVS Monitor News

VivoSim Labs Inc Surges Amid Market Decline

Jan 30 2026

VIVS Earnings Analysis

No Data

No Data

People Also Watch